Valuation: RushNet, Inc.

Market Cap 12.26M 10.78M 10.04M 9.22M 17.31M 1.18B 17.54M 119M 46.59M 581M 46.04M 45.05M 2.01B P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 18.19M 15.99M 14.89M 13.67M 25.67M 1.74B 26.01M 177M 69.12M 862M 68.3M 66.82M 2.98B EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.01
10 years 0
Extreme 0
0.02
Manager TitleAgeSince
Chief Executive Officer - 03/03/2024
Chief Operating Officer 45 01/08/2021
Director TitleAgeSince
Chairman - 03/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - -83.33% 8.77K
+0.56%+10.50%-16.51%+55.11% 6.41B
+1.31%+0.81%-7.06%-8.18% 4.79B
+1.64%-11.96%-15.25% - 2.12B
-1.09%-2.79%+61.56%+1,928.54% 1.62B
+0.62%+3.37%-7.05%-31.32% 1.45B
+0.13%+0.77%-6.36%-38.75% 1.32B
-2.22%-3.52%+197.16% - 1.06B
+1.08%-0.99%-26.85%-31.46% 778M
+0.09%+1.25%-3.40%-13.82% 630M
Average +0.19%-0.56%+19.58%+222.10% 2.02B
Weighted average by Cap. +0.50%+0.98%+4.73%+194.43%

Financials

2020 2021
Net sales 4.39M 3.86M 3.59M 3.3M 6.19M 421M 6.27M 42.68M 16.67M 208M 16.47M 16.12M 718M 5.9M 5.18M 4.83M 4.43M 8.32M 565M 8.43M 57.36M 22.4M 279M 22.14M 21.66M 965M
Net income 991K 871K 811K 745K 1.4M 95.01M 1.42M 9.64M 3.76M 46.91M 3.72M 3.64M 162M 164K 144K 134K 123K 231K 15.69M 234K 1.59M 621K 7.75M 614K 601K 26.77M
Net Debt 5.87M 5.16M 4.8M 4.41M 8.28M 563M 8.39M 57.1M 22.3M 278M 22.04M 21.56M 961M 5.93M 5.21M 4.85M 4.46M 8.37M 569M 8.48M 57.67M 22.52M 281M 22.26M 21.78M 970M
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
24/07/26 US$0.000001 -.--% 30,000
23/07/26 US$0.000001 -.--% 1,500
  1. Stock Market
  2. Stocks
  3. RSHN Stock